Unichem Laboratories (NSE:UNICHEMLAB) Institutional Ownership: 9.76% (As of Jul. 12, 2026)


NSE:UNICHEMLAB Unichem Laboratories Ltd NSE:UNICHEMLAB
78 GF Score
Price ₹638.75
GF Value ₹692.03
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Unichem Laboratories Institutional Ownership?

Unichem Laboratories NSE:UNICHEMLAB -1.82% 78 Institutional Ownership is 9.76% as of Jul. 12, 2026. GuruFocus rates NSE:UNICHEMLAB with a GF Score™ of 78/100 and a GF Value™ of ₹692.03 (Fairly Valued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Unichem Laboratories's institutional ownership is 9.76%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Unichem Laboratories's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Unichem Laboratories's Float Percentage Of Total Shares Outstanding is 0.00%.

Unichem Laboratories Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Unichem Laboratories's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unichem Laboratories Institutional Ownership Chart

Unichem Laboratories Historical Data

The historical data trend for Unichem Laboratories can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 10.00 10.00 10.00 10.00 10.00 9.97 9.88 9.76 9.76 9.76
NSE:UNICHEMLAB
78GF Score
Unichem Laboratories Ltd NSE:UNICHEMLAB
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Unichem Laboratories Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 9.76% mean?
Unichem Laboratories (NSE:UNICHEMLAB) has a Institutional Ownership of 9.76% as of Jul. 12, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Unichem Laboratories and its competitors.
Is Unichem Laboratories' Institutional Ownership too high?
Unichem Laboratories' current Institutional Ownership is 9.76%. Overall, Unichem Laboratories has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Unichem Laboratories' Institutional Ownership compare to ZTS and UTHR?
Unichem Laboratories' Institutional Ownership of 9.76% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Unichem Laboratories and its competitors. Unichem Laboratories's current Institutional Ownership is 9.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unichem Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Unichem Laboratories (NSE:UNICHEMLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹692.03, compared to a current price of ₹638.75 — trading 7.7% below its estimated fair value. The current Institutional Ownership is 9.76%. Unichem Laboratories' overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Unichem Laboratories (NSE:UNICHEMLAB), the current Institutional Ownership is 9.76% as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Unichem Laboratories (NSE:UNICHEMLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Unichem Laboratories stock appears to be undervalued. The current stock price of ₹638.75 is trading 7.7% below its estimated GF Value™ of ₹692.03. GuruFocus considers Unichem Laboratories to be Fairly Valued.

Key valuation signals for NSE:UNICHEMLAB:

  • Institutional Ownership: 9.76%
  • GF Value™: ₹692.03 vs. price of ₹638.75 (7.7% below fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the NSE:UNICHEMLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Unichem Laboratories Business Description

Other Exchanges 506690:India
Address Off. S. V. Road, Unichem Bhavan, Prabhat Estate, Jogeshwari (West), Mumbai, MH, IND, 400 102
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.
78GF Score

Get the complete analysis for NSE:UNICHEMLAB

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹638.75
Price
₹692.03
GF Value